Medigen Biotechnology Corp. (TPEX:3176)

Medigen Biotechnology Statistics

Total Valuation

TPEX:3176 has a market cap or net worth of TWD 4.17 billion. The enterprise value is 5.94 billion.

Market Cap	4.17B
Enterprise Value	5.94B

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:3176 has 139.31 million shares outstanding. The number of shares has decreased by -0.03% in one year.

Current Share Class	139.31M
Shares Outstanding	139.31M
Shares Change (YoY)	-0.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.56%
Owned by Institutions (%)	4.12%
Float	109.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.56
PB Ratio	0.84
P/TBV Ratio	2.62
P/FCF Ratio	1,076.98
P/OCF Ratio	80.53
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 38.56, with an EV/FCF ratio of 1,532.46.

EV / Earnings	-77.64
EV / Sales	3.65
EV / EBITDA	38.56
EV / EBIT	n/a
EV / FCF	1,532.46

Financial Position

The company has a current ratio of 4.43, with a Debt / Equity ratio of 0.19.

Current Ratio	4.43
Quick Ratio	3.51
Debt / Equity	0.19
Debt / EBITDA	5.82
Debt / FCF	243.56
Interest Coverage	-0.44

Financial Efficiency

Return on equity (ROE) is -2.80% and return on invested capital (ROIC) is -0.11%.

Return on Equity (ROE)	-2.80%
Return on Assets (ROA)	-0.10%
Return on Invested Capital (ROIC)	-0.11%
Return on Capital Employed (ROCE)	-0.18%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.24
Inventory Turnover	1.02

Taxes

In the past 12 months, TPEX:3176 has paid 105.86 million in taxes.

Income Tax	105.86M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.60% in the last 52 weeks. The beta is 0.36, so TPEX:3176's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-19.60%
50-Day Moving Average	29.40
200-Day Moving Average	31.30
Relative Strength Index (RSI)	58.83
Average Volume (20 Days)	165,869

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:3176 had revenue of TWD 1.63 billion and -76.46 million in losses. Loss per share was -0.55.

Revenue	1.63B
Gross Profit	949.34M
Operating Income	-10.48M
Pretax Income	-35.11M
Net Income	-76.46M
EBITDA	138.28M
EBIT	-10.48M
Loss Per Share	-0.55

Balance Sheet

The company has 2.46 billion in cash and 943.54 million in debt, giving a net cash position of 1.52 billion or 10.90 per share.

Cash & Cash Equivalents	2.46B
Total Debt	943.54M
Net Cash	1.52B
Net Cash Per Share	10.90
Equity (Book Value)	4.97B
Book Value Per Share	12.14
Working Capital	2.80B

Cash Flow

In the last 12 months, operating cash flow was 51.81 million and capital expenditures -47.93 million, giving a free cash flow of 3.87 million.

Operating Cash Flow	51.81M
Capital Expenditures	-47.93M
Free Cash Flow	3.87M
FCF Per Share	0.03

Margins

Gross margin is 58.33%, with operating and profit margins of -0.64% and -4.70%.

Gross Margin	58.33%
Operating Margin	-0.64%
Pretax Margin	-2.16%
Profit Margin	-4.70%
EBITDA Margin	8.50%
EBIT Margin	-0.64%
FCF Margin	0.24%

Dividends & Yields

TPEX:3176 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.03%
Shareholder Yield	0.03%
Earnings Yield	-1.83%
FCF Yield	0.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:3176 has an Altman Z-Score of 2.6 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.6
Piotroski F-Score	5